The University of Ottawa Heart Institute Transplant Program was established in 1984. Averaging 25 heart transplants a year, approximately 350 patients have received transplants to date.
Referrals are received from all over the country for patients requiring artificial devices. Three types of devices are used: the Jarvik (artificial heart), the Novocor and Thoratec (Ventricular Assist Devices).
Patients are transplanted for end-stage heart failure due to ischemic heart disease or cardiomyopathy (heart muscle dysfunction) related to viral infection arising from other causes that could affect persons of all ages.
- First program in Canada to use the artificial heart (Jarvik) as a bridge to transplant in 1986
- Youngest pediatric heart transplant (11 days old) in 1989
- Permanent artificial heart called the heart saver being developed along with the World Heart Organization
Heart recipients have formed the Heart Transplant Association. This association is very active in public awareness and fund raising. Recipients & spouses can be involved in a “peer mentorship program”, in which they meet and support patients awaiting heart transplantation.
Surgical Director: Dr. Thierry Mesana
Medical Director: Dr. Haissam Haddad
Transplant Coordinator: Carolyn Pugliese, RN MScN